Papadopoulos Stelios
CIK 0001202098
Director
Filings
22
Latest May 29, 2026
Issuers covered
4
Showing
22 of 22
Page 1
Track record
5 of 5 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 5 | 60% | +2.5% | +6.2% | +9.7% | -9.8% |
| 90 days | 5 | 80% | +3.6% | +9.4% | +16.8% | -26.3% |
| 180 days | 5 | 60% | -12.3% | +2.3% | +7.1% | -63.9% |
| 365 days | 4 | 25% | -29.0% | -8.4% | +11.4% | -110.6% |
Issuers
Companies where Papadopoulos Stelios has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| EXEL | Exelixis, Inc. | 9 | May 29, 2026 |
| RGLS | Regulus Therapeutics Inc. | 9 | Jun 27, 2025 |
| OVID | Ovid Therapeutics Inc. | 3 | Apr 9, 2026 |
| BIIB | Biogen Inc. | 1 | Jun 17, 2022 |
All filings
22 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|